bell
The current prices are delayed by 15 mins, login to check live prices.
Sequent Scientific Ltd share price logo

Sequent Scientific Ltd

(SEQUENT)

₹172.911.42%

as on 04:01PM, 26 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Sequent Scientific Ltd Share analysis

Excluding Excise Duty and Other Income, represents Net Revenue

Sequent Scientific Ltd revenue growth forecast

Expected growth rate Q1, FY2022:2.45%

Forecast

Actual

Source: S&P Global Market Intelligence

Sequent Scientific Ltd Performance

  • Day's Low

    Day's High

    ₹171.95
    Day's Price Range
    ₹178.5
  • 52 Week's Low

    52 Week's High

    ₹92.05
    52-Week Price Range
    ₹240.7
1 Month Return-11.49 %
3 Month Return-19.27 %
1 Year Return+ 49.4 %
Previous Close₹175.40
Open₹178.30
Volume1.38L
Upper Circuit-
Lower Circuit-
Market Cap₹4,390.30Cr

Sequent Scientific Ltd Key Statistics

P/E Ratio265.76
PEG Ratio40.7
Market Cap₹4,390.30 Cr
P/B Ratio2.65
EPS-1.19
Dividend Yield0
SectorPharmaceuticals
ROE0.22

Sequent Scientific Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹4,390.30 Cr29.1%0.52-₹30 Cr₹1,369 Cr
HOLD₹30,578.42 Cr138.51%0.67₹168 Cr₹5,040 Cr
NA₹8,972.21 Cr5.36%0.53NANA
NA₹15.34 Cr-9.23%0.50-₹2 Cr₹35 Cr
NA₹282.01 Cr97.9%0.50NANA

About Sequent Scientific Ltd

Visistha Traders Finance Ltd has combined itself with PI Drugs and Pharmaceuticals Ltd. Confirmation of amalgamation was approved by the High Court on November 12th 2003. As a result, one of the leading companies in the Indian pharmaceutical industry is now under its wing. It is anticipated that the move will benefit both the companies, shareholders and society at large. It will help Visistha Traders further solidify its creative and enterprising portfolio while aiding PI Drugs expand its reach and customer base. The amalgamation will make it easier to access the required resources, human and capital in a more efficient manner. Another positive factor of this step is that it will reduce administrative costs, allowing for a more productive use of resources. Combining the skill sets of both firms also ensures the sector benefits the most efficient and cutting-edge solutions. All in all, this is a step that is expected to lead to a brighter future for the pharmaceutical sector.

Share Price: ₹172.91 per share as on 26 Dec, 2024 04:01 PM
Market Capitalisation: ₹4,390.30Cr as of today
Revenue: ₹368.65Cr as on September 2024 (Q3 24)
Net Profit: ₹6.34Cr as on September 2024 (Q3 24)
Listing date: 10 Mar, 2016
Chairperson Name: Kamal K Sharma
OrganisationSequent Scientific Ltd
HeadquartersBangalore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sequent Scientific Ltd

  • Sequent Scientific Reports Strong Q3 Performance - 29 Nov, 2024

    Sequent Scientific reported a 6.56% increase in net sales to Rs 368.65 crore for September 2024. Net profit surged 175.66% to Rs 6.34 crore, while EBITDA rose 159.89% to Rs 43.61 crore. The company's shares have delivered impressive returns of 90.60% over the last six months.
  • Sequent Scientific Reports Decline in Net Sales - 26 Nov, 2024

    Sequent Scientific's standalone net sales for September 2024 fell to Rs 41.99 crore, a decrease of 14.51% year-on-year. Despite this, the company reported a net profit of Rs 4.26 crore.
  • Sequent Scientific Achieves Full Ownership of Subsidiaries - 22 Nov, 2024

    Sequent Scientific has successfully acquired full ownership of N-VET AB in Sweden and Alivira Italia SRL in Italy, enhancing its operational control and market presence in animal healthcare.

Insights on Sequent Scientific Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.69% to 7.41% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.70% to 6.45% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 49.7% return, outperforming this stock by 2.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.1% return, outperforming this stock by 117.2%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 52.78% to 52.76% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 6.51 Cr → 2.61 Cr (in ₹), with an average decrease of 59.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 392.89 Cr → 373.16 Cr (in ₹), with an average decrease of 5.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SEQUENT stock has moved down by -11.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 33.30% to 30.63% in Sep 2024 quarter

Sequent Scientific Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹345.97Cr (-)₹329.36Cr (↓4.80%)₹361.20Cr (↑9.67%)₹390.21Cr (↑8.03%)₹368.65Cr (↓5.53%)
Net Income-₹6.88Cr (-)₹10.68Cr (↓255.23%)₹1.27Cr (↓88.11%)₹9.06Cr (↑613.39%)₹6.34Cr (↓30.02%)
Net Profit Margin-1.99% (-)3.24% (↓262.81%)0.35% (↓89.20%)2.32% (↑562.86%)1.72% (↓25.86%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,109.00Cr (-)₹1,126.52Cr (↑1.58%)₹1,122.92Cr (↓0.32%)₹1,187.60Cr (↑5.76%)
Total Liabilities₹79.49Cr (-)₹85.43Cr (↑7.47%)₹64.55Cr (↓24.44%)₹100.37Cr (↑55.49%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹30.20Cr (-)₹2.34Cr (↓92.25%)₹9.36Cr (↑300.00%)₹37.75Cr (↑303.31%)-₹26.94Cr (↓171.36%)

Index Inclusions

BSE Healthcare

₹44,289.95

0.45 (197.91%)

BSE Small-Cap

₹54,893.21

-0.24 (-129.96%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Sequent Scientific Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
52.76%
-0.04
Foreign Institutions
6.45%
13.21
Mutual Funds
7.41%
30.35
Retail Investors
30.63%
-8.00
Others
2.75%
8.19

Sequent Scientific Ltd Key Indicators

Details20202021202220232024
Return On Equity %2.233.271.43-0.580.22
Details20202021202220232024
Return On Assets %78.613.64-10.79-3.02
Details20202021202220232024
Book Value Per Share (₹)27.6629.327.528.0126.32
Details20202021202220232024
Earning Per Share (₹)3.34.211.8-4.89-1.19

Sequent Scientific Ltd Valuation

Sequent Scientific Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-117.80x)

January 17, 2023

Industry (56.56x)

December 24, 2024

Today (265.76x)

December 24, 2024

Highest (1034.67x)

September 27, 2024

LowHigh

Sequent Scientific Ltd Earnings and Dividends

  • Sequent Scientific Ltd Earnings Results

    Sequent Scientific Ltd’s net profit jumped 131.15% since last year same period to ₹2.61Cr in the Q2 2024-2025. On a quarterly growth basis, Sequent Scientific Ltd has generated -59.91% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Sequent Scientific Ltd Dividends June,2021

    In the quarter ending March 2021, Sequent Scientific Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.29%.

    Read More about Dividends

Sequent Scientific Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sequent Scientific Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Sequent Scientific Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sequent Scientific Ltd shares.

Sequent Scientific Ltd (SEQUENT) share price today is ₹172.91

Sequent Scientific Ltd is listed on NSE

Sequent Scientific Ltd is listed on BSE

  • Today’s highest price of Sequent Scientific Ltd is ₹178.5.
  • Today’s lowest price of Sequent Scientific Ltd is ₹171.95.

PE Ratio of Sequent Scientific Ltd is 265.76

PE ratio = Sequent Scientific Ltd Market price per share / Sequent Scientific Ltd Earnings per share

Today’s traded volume of Sequent Scientific Ltd(SEQUENT) is 1.38L.

Today’s market capitalisation of Sequent Scientific Ltd(SEQUENT) is ₹4390.3Cr.

Sequent Scientific Ltd(SEQUENTPrice
52 Week High
₹240.7
52 Week Low
₹92.05

Sequent Scientific Ltd(SEQUENT) share price is ₹172.91. It is down -28.16% from its 52 Week High price of ₹240.7

Sequent Scientific Ltd(SEQUENT) share price is ₹172.91. It is up 87.84% from its 52 Week Low price of ₹92.05

Sequent Scientific Ltd(SEQUENTReturns
1 Day Returns
-2.49%
1 Month Returns
-11.49%
3 Month Returns
-19.27%
1 Year Returns
49.4%